Sodium Hyaluronate [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2010-02-01 14:09 (5993 d 07:46 ago) – Posting: # 4676
Views: 3,043

Dear Raghavendra!

❝ How to assess the euivalence for Generic Sodium HYALURONATE

❝ Injections for Osteoarthritis?

❝ Is it required only Clinical End Point study or also the Bioequivalence

❝ Study?

  1. Do you believe you can show superiority to placebo with this kind of product? You know that there's no clear clinical evidence of efficacy yet.
  2. No way. The daily turnover of hyalurnic acid are a couple of grams - you will never be able to see a shift against such high endogenous levels.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
203 visitors (0 registered, 203 guests [including 16 identified bots]).
Forum time: 22:56 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5